New UK Industry Body To Promote Flagging Biosimilar Market
This article was originally published in Scrip
The British Generic Manufacturers Association has become the latest pharmaceutical trade body to set up a dedicated sector group to promote the use of biosimilar medicines, following a similar move by Medicines for Europe, which represents national generic associations across Europe.
You may also be interested in...
As Europe’s health emergency body HERA approaches its first anniversary, an unprecedented range of stakeholders including industry bodies will be meeting in December to discuss HERA’s achievements, while a separate event will showcase the next generation of vaccines for COVID-19 and other infections.
The European health commissioner has told members of parliament that a balance needs to be struck between promoting innovation and maximizing access to medicines across the EU member states.
Hot on the heels of its new antimalarial strategy, the World Health Organization has given a “strong” recommendation for the use of a fixed-dose artemisinin combination therapy from Shin Poong and the Medicines for Malaria Venture that should see it being more widely used in disease-endemic countries.